Phibro Animal Health is a global animal health and nutrition company that develops and manufactures products primarily for food animals, including poultry, cattle, swine, and aquaculture. The company operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. Its core Animal Health segment provides medicated feed additives—such as antibacterials and anticoccidials—as well as proprietary nutritional supplements and vaccines that prevent disease, improve digestive health, and support livestock growth. Phibro also produces trace mineral premixes that fortify animal feed, alongside specialty chemical ingredients. Phibro sells recurring consumables administered through animal feed or water, tying its revenue directly to global livestock production volumes. The company distributes products globally to large integrated livestock producers, feed manufacturers, distributors, and veterinarians, supporting sales with technical field teams of veterinarians and nutritionists. Phibro's growth strategy centers on expanding its medicated feed additive portfolio, driving operational efficiencies and pricing realization, and expanding into niche companion animal products.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →